NIB Holdings Ltd (ASX: NHF) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

NIB Holdings Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $3.56 billion
P/E Ratio 17.35
Dividend Yield 4.09%
Shares Outstanding 485.08 million
Earnings per share 0.422
Dividend per share 0.30
Year To Date Return 1.22%
Earnings Yield 5.76%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • NIB Holdings Ltd (ASX: NHF)
    Latest News

    Two businessmen look out at the city from the top of a tall building.
    Broker Notes

    Buy or hold? Top broker rates these 2 ASX 200 shares

    One player stands out more than the other.

    Read more »

    A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
    Dividend Investing

    Brokers say these ASX dividend shares are top buys now

    Analysts have good things to say about these income options.

    Read more »

    Man holding fifty Australian Dollar banknote in his hands, symbolising dividends, symbolising dividends.
    Dividend Investing

    Buy these ASX dividend stocks for a passive income boost

    Analysts think income investors should be buying these income stocks.

    Read more »

    Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    The ASX 200 had a day to remember today, rising a huge 1.44%.

    Read more »

    Male hands holding Australian dollar banknotes, symbolising dividends.
    Dividend Investing

    Here are 3 ASX income shares to buy in May

    Analysts have buy ratings on these stocks. But why?

    Read more »

    Woman calculating dividends on calculator and working on a laptop.
    Dividend Investing

    3 ASX 300 dividend stocks to buy now for income

    Brokers think these dividend stocks are buys right now. What sort of yields are they forecasting?

    Read more »

    A female stockbroker reviews share price performance in her office with the city shown in the background through her windows
    Share Market News

    5 things to watch on the ASX 200 on Wednesday

    Another positive session is expected for investors today.

    Read more »

    A businessman keeps calm in the face of inflation
    Opinions

    Forget gold! I'd buy these top ASX shares to beat inflation

    Find out why gold isn't my preference for escaping inflation's wealth-eating habit.

    Read more »

    a man with a wide, eager smile on his face holds up three fingers.
    Opinions

    3 top income-focused ASX shares to buy before April

    I'd bolster my income by buying these dividend-payers before the next month rolls around.

    Read more »

    A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
    Share Market News

    Here's how the ASX 200 market sectors stacked up this week

    ASX financial shares led the 11 market sectors this week amid the ASX 200 rising 1.07%.

    Read more »

    Health professional working on his laptop.
    Healthcare Shares

    Why Medibank and NIB shares are outperforming today

    Premium increases for 2024 have been announced.

    Read more »

    A man sits bolt upright watching something intently on his television.
    Dividend Investing

    34 ASX 200 shares with ex-dividend dates next week

    Do you own any of the 34 stocks set to cut off dividend eligibility next week?

    Read more »

    Frequently Asked Questions

    The company was established as Newcastle Industrial Benefits (NIB) Hospital Fund in 1952 to provide health insurance for workers at BHP Steelworks, Mayfield. It changed its name to NIB Health Funds Ltd in 1966.

    In 2007 members voted in favour of demutualising the health fund, and in November that year, NIB became the first Australian private health insurer to list on the ASX.

    NIB has paid out twice-yearly dividends – in April and October — every year since 2009. Its latest payout was a final dividend of 11 cents a share in October 2022.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    07 Mar 2024 $0.1500 100.00% Interim 10 Apr 2024
    04 Sep 2023 $0.1500 100.00% Final 03 Oct 2023
    02 Mar 2023 $0.1300 100.00% Interim 03 Apr 2023
    05 Sep 2022 $0.1100 100.00% Final 04 Oct 2022
    03 Mar 2022 $0.1100 100.00% Interim 04 Apr 2022
    02 Sep 2021 $0.1400 100.00% Final 05 Oct 2021
    04 Mar 2021 $0.1000 100.00% Interim 06 Apr 2021
    03 Sep 2020 $0.0400 100.00% Final 06 Oct 2020
    05 Mar 2020 $0.1000 100.00% Interim 07 Apr 2020
    02 Sep 2019 $0.1300 100.00% Final 30 Sep 2019
    06 Sep 2018 $0.1100 100.00% Final 05 Oct 2018
    01 Mar 2018 $0.0900 100.00% Interim 03 Apr 2018
    07 Sep 2017 $0.0000 100.00% Final 06 Oct 2017
    02 Mar 2017 $0.0850 100.00% Interim 03 Apr 2017
    08 Sep 2016 $0.0900 100.00% Final 07 Oct 2016
    02 Mar 2016 $0.0575 100.00% Interim 01 Apr 2016
    10 Sep 2014 $0.0900 100.00% Special Cash 03 Oct 2014
    10 Sep 2014 $0.0575 100.00% Final 03 Oct 2014
    05 Sep 2013 $0.0500 100.00% Final 04 Oct 2013
    04 Mar 2013 $0.0500 100.00% Interim 05 Apr 2013
    05 Mar 2012 $0.0425 100.00% Interim 05 Apr 2012
    07 Mar 2011 $0.0400 100.00% Interim 08 Apr 2011
    05 Mar 2010 $0.0200 100.00% Interim 08 Apr 2010
    14 Sep 2009 $0.0440 100.00% Final 09 Oct 2009

    NHF ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About NIB Holdings Ltd

    NIB Holdings Limited (ASX: NHF) provides health and medical insurance to more than 1.5 million Australian and New Zealand residents.

    In addition, it covers more than 180,000 international students and workers in Australia.

    The company also offers travel insurance through its NIB Travel business,  and provides health insurance plans to corporate groups through its GU Health business.

    The NIB share price hit an all-time high of $8.18 on 31 August 2022.

    NHF Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    21 Jun 2024 $7.33 $0.10 1.38% 1,917,040 $7.30 $7.33 $7.26
    20 Jun 2024 $7.23 $-0.07 -0.96% 1,204,986 $7.24 $7.32 $7.21
    19 Jun 2024 $7.30 $-0.23 -3.05% 876,271 $7.46 $7.51 $7.29
    18 Jun 2024 $7.53 $0.03 0.40% 958,378 $7.60 $7.60 $7.52
    17 Jun 2024 $7.50 $0.17 2.32% 828,803 $7.37 $7.50 $7.35
    14 Jun 2024 $7.33 $-0.03 -0.41% 483,330 $7.41 $7.41 $7.32
    13 Jun 2024 $7.36 $-0.04 -0.54% 840,200 $7.43 $7.44 $7.26
    12 Jun 2024 $7.40 $-0.07 -0.94% 473,110 $7.47 $7.50 $7.39
    11 Jun 2024 $7.47 $-0.11 -1.45% 804,975 $7.54 $7.54 $7.44
    07 Jun 2024 $7.58 $0.04 0.53% 458,912 $7.56 $7.59 $7.49
    06 Jun 2024 $7.54 $0.08 1.07% 469,921 $7.50 $7.55 $7.46
    05 Jun 2024 $7.46 $0.06 0.81% 716,143 $7.47 $7.52 $7.41
    04 Jun 2024 $7.40 $-0.12 -1.60% 711,675 $7.51 $7.55 $7.40
    03 Jun 2024 $7.52 $0.08 1.08% 937,268 $7.49 $7.55 $7.47
    31 May 2024 $7.44 $0.08 1.09% 1,132,779 $7.41 $7.47 $7.32
    30 May 2024 $7.36 $0.09 1.24% 930,353 $7.23 $7.36 $7.23
    29 May 2024 $7.27 $0.09 1.25% 1,437,890 $7.20 $7.33 $7.20
    28 May 2024 $7.18 $0.03 0.42% 2,647,009 $7.18 $7.27 $7.16
    27 May 2024 $7.15 $0.09 1.27% 796,827 $7.10 $7.17 $7.06
    24 May 2024 $7.06 $-0.08 -1.12% 739,646 $7.11 $7.13 $7.03

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    18 Apr 2024 Mark Fitzgibbon Transfer 20,000 $152,000
    Off-market transfer.
    18 Apr 2024 Mark Fitzgibbon Transfer 20,000 $152,000
    Off-market transfer.
    12 Mar 2024 Mark Fitzgibbon Sell 35,000 $277,018
    On-market trade.
    08 Dec 2023 Jill Watts Buy 3,154 $23,497
    On-market trade.
    01 Dec 2023 Mark Fitzgibbon Issued 195,046 $1,503,804
    Issue of securities. 9,19,837 Rights
    23 Nov 2023 Mark Fitzgibbon Transfer 22,000 $165,000
    Off-market transfer.
    23 Nov 2023 Mark Fitzgibbon Transfer 22,000 $165,000
    Off-market transfer.
    22 Nov 2023 Jill Watts Buy 162 $1,200
    On-market trade.
    20 Nov 2023 Jill Watts Buy 4,021 $29,996
    On-market trade.
    01 Sep 2023 Mark Fitzgibbon Issued 86,977 $716,690
    Issue of securities.
    01 Sep 2023 Mark Fitzgibbon Exercise 139,730 $1,151,375
    Conversion of securities. 7,85,693 Rights
    01 Sep 2023 Mark Fitzgibbon Issued 139,730 $1,151,375
    Conversion of securities.
    01 Sep 2023 Mark Fitzgibbon Expiry 60,902 $501,832
    As advised by the company. Lapsed, 7,24,791 Rights
    01 Sep 2023 Mark Fitzgibbon Sell 35,000 $288,464
    On-market trade.
    31 Aug 2023 Mark Fitzgibbon Sell 35,000 $290,511
    On-market trade.
    28 Aug 2023 Mark Fitzgibbon Transfer 30,000 $243,000
    Off-market transfer.
    28 Aug 2023 Mark Fitzgibbon Transfer 30,000 $243,000
    Off-market transfer.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David L Gordon Non-Executive DirectorNon-Executive Chairman May 2020
    Mr Gordon has over 30 years of experience as a director of both public and private companies and in corporate advisory roles to Australian and international organizations. He brings knowledge of mergers and acquisitions, as well as capital raisings, IPOs, and joint ventures. He also has a track record in guiding businesses to grow and harness their digital capability to explore and develop new products and markets. He has held several senior roles with Freehills (Partner) and boutique investment bank Wentworth Associates (acquired by Investec in 2001). In addition, he founded independent corporate advisory and investment firm, Lexicon Partners in 2001.
    Ms Anne Joan Loveridge Non-Executive Director Feb 2017
    Ms Loveridge has over 35 years of experience in the regulated financial services sector, including health insurance. She has knowledge of financial and regulatory reporting, risk management and compliance frameworks. She also has over seven years of experience as a Non-Executive Director for ASX-listed entities in the financial services sector. Through senior leadership roles, Anne also has supported the role of leadership, performance, and culture in driving change. Formally trained as a Chartered Accountant, Anne has a breadth of experience in financial reporting, auditing, risk, ethics, and regulatory affairs following her 31 years with PwC in the UK and Australia, where she was a Senior Audit Partner and Deputy Chair of the Australian Firm until 2015. She is member of the Risk and Reputation Committee.
    Mr Donal Paul O'Dwyer Non-Executive Director Mar 2016
    Mr O'Dwyer has knowledge of the health industry globally, after more than 35 years in senior executive and Non-Executive Director roles within the healthcare products and medical device sectors. Starting his career as a qualified civil engineer, he went on to gain experience in business, science, engineering, manufacturing, and management. During his tenure with Baxter Healthcare, he rose through the ranks from plant manager to President of the Cardiovascular Group Europe, gaining understanding of the inner workings of business strategy and fiscal management, from the floor of the factory through to the boardroom. He then worked for Cordis (the cardiovascular device franchise of Johnson and Johnson) initially as European President and later, when he located to the US, he served as Worldwide President.
    Mark Fitzgibbon Chief Executive OfficerManaging Director May 2007
    Mr Fitzgibbon has held executive positions at several Australian organizations, including local government councils and peak bodies. Leading nib for the past 20 years, he has changed the business from a regionally based (Newcastle, NSW) private health insurer into one of Australia's growing and innovative health funds. As Managing Director, Mark's strategic focus has been to grow and diversify nib's business and with those earnings by leveraging nib's capability, systems, and people. This has seen nib grow in recent years organically and inorganically, both in existing and new markets.
    Mr Peter Harmer Non-Executive Director Jul 2021
    Mr Harmer has over 40 years of experience in the Australian and international insurance and financial sectors, including over 30 years in a senior executive capacity. He understands the global insurance and reinsurance markets and has driven the improvement of business and customer experiences through digital innovation. During his career, Peter enhanced digital engagement through reexamining customer journeys to understand pain points and introduced the right tools and technology to help improve the overall customer experience. In addition, he has been focused on the development and design of agile working methodologies combined with Human Centred Design thinking to ensure best practice in employee productivity, performance, health, and wellbeing. He is the Chair of the Risk and Reputation Committee.
    Ms Jacqueline Chow Non-Executive Director Apr 2018
    Ms Chow has more than 20 years of experience working with global blue-chip consumer product multinationals in a range of executive and non-executive positions in general management, strategy, marketing as well as technology and innovation. Her early career concentrated on business analytics, brand equity and marketing. With a reputation for driving growth and performance in global businesses, she is passionate about unlocking value through the entire value chain by growing consumer demand through disruptive technologies, innovation, and digital platforms. Jacqueline actively contributes toward ensuring the long-term sustainability of the organizations she serves in the areas of climate scenario impacts, human rights, and supply chain resilience.
    Mr Brad Welsh Non-Executive Director Jul 2023
    Mr Welsh, who has spent more than a decade leading and advising global resource companies including Energy Resources of Australia and Rio Tinto, brings both public sector and commercial skills to his role on nibs Board. He is currently Chief Executive Officer and Managing Director at Energy Resources of Australia. Among his previous roles he was Chief Adviser to the CEO - Indigenous Affairs, at Rio Tinto; Acting General Manager, Weipa, at Rio Tinto, and worked in the Office of the NSW Premier, the Minister for Planning, and the Prime Minister of Australia.
    Ms Jill Watts Non-Executive Director Jul 2023
    Ms Watts is a Non-Executive Director on the Boards of St Vincents Healthcare, Icon Cancer Group and IHH Healthcare Berhad, which is listed in Malaysia and Singapore, and has operations in Turkey, India, China, and Europe. She is on the Board of Lendleases retirement living business, known as Keyton. Prior to returning to Australia in 2017, she was the Group CEO of the UKs private hospital group BMI Healthcare, and Group CEO of Ramsay Healthcare, UK.
    Ms Roslyn Toms Group Executive - Legal and Chief Risk OfficerCompany Secretary Apr 2013
    -
    Mr Jordan French Senior Corporate CounselJoint Company Secretary Aug 2017
    -
    Edward Close Chief Executive - Australian Residents Health Insurance
    -
    James Barr Chief Executive - International Visitors
    -
    Martin Adlington Chief Executive - nib Thrive
    -
    Rob Hennin Chief Executive Officer - nib New Zealand and Travel
    -
    Nick Freeman Group Chief Financial Officer
    -
    Brendan Mills Group Chief Information Officer
    -
    Lauren Daniels Group Chief People Officer
    -
    Roslyn Toms Group Executive - Legal and Chief Risk Officer
    -
    Roslyn Toms Group Executive - Legal and Chief Risk OfficerCompany Secretary
    -
    Jordan French Senior Corporate CounselJoint Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 77,169,011 15.96%
    Citicorp Nominees Pty Limited 47,951,542 9.93%
    J P Morgan Nominees Australia Pty Limited 47,754,468 9.88%
    National Nominees Limited 19,129,457 3.96%
    BNP Paribas Noms Pty Ltd 13,107,907 2.72%
    HSBC Custody Nominees (Australia) Limited i 4,724,867 0.98%
    Bnp Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd 2,775,852 0.57%
    Citicorp Nominees Pty Limited i 2,517,739 0.52%
    BNP Paribas Nominees Pty Ltd 1,806,166 0.37%
    BNP Paribas Noms (Nz) Ltd 1,311,537 0.27%
    HSBC Custody Nominees (Australia) Limited ii 1,201,417 0.25%
    Mr Mark Anthony Fitzgibbon 1,084,491 0.22%
    BNP Paribas Nominees Pty Ltd i 1,015,082 0.20%
    Netwealth Investments Limited 874,961 0.18%
    Fitzy (Nsw) Pty Ltd 874,621 0.18%
    Cpu Share Plans Pty Ltd 779,213 0.16%
    Cpu Share Plans Pty Ltd i 641,555 0.13%
    Netwealth Investments Limited i 608,834 0.13%
    Neweconomy Com Au Nominees Pty Limited 553,327 0.11%
    Cpu Share Plans Pty Ltd ii 542,190 0.11%

    Profile

    since

    Note